3 Reasons to Buy Allergan plc Stock Right Now

Allergan (NYSE: AGN) is one of the most underappreciated big pharma stocks on the market right now. That's the thought that occurred to me as I listened to Brent Saunders, Allergan's CEO, speak at the Wells Fargo Healthcare Conference on Thursday.

One thing's for sure, though: Underappreciated stocks don't stay that way for too long. Investors eventually begin to see the value in the stock, interest increases, and the stock moves higher. I think that's going to happen with Allergan. Here are three top reasons investors should consider buying this big pharma stock right now.

Image source: Getty Images.

Source: Fool.com